SEC Form 4 · accession 0001062993-15-003950
BIOSPECIFICS TECHNOLOGIES CORP · BSTC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Gitman
Director
Period of report
Jul 20, 2015
Accepted (ET)
Jul 21, 2015 · 9:53 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875622
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value | Jul 20, 2015 | M | 8,692 | $13.60 | A | 60,517 | D | |
| Common Stock, $0.001 par valueF2 | Jul 20, 2015 | S | 8,692 | $53.00 | D | 51,825 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $13.60 | Jul 20, 2015 | M | 8,692 | D | — | Jun 9, 2018 | Common Stock, $0.001 par value | 8,692 | 0 | D |
Explanation of responses
- F1The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2015.
- F2All 8,692 shares sold on July 20, 2015 were executed at a price point of $53.00.
- F3The option was granted on June 10, 2008 and it was to vest monthly with respect to 1/12 of the total number of shares until all shares underlying the option have vested. All shares underlying the option have vested.